Stay updated on Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:35:01.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the recommended phase II dose of M7824 and radiation therapy for patients with metastatic hormone receptor positive, HER2 negative breast cancer in a clinical trial setting.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:10.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including the requirement for written informed consent and specific health conditions. Previously, this section only indicated that no information was provided.
    Difference
    41%
    Check dated 2024-05-22T21:29:56.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:31:41.000Z thumbnail image

Stay in the know with updates to Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation Therapy and M7824 in Metastatic Breast Cancer Clinical Trial page.